Literature DB >> 6085815

Serum ferritin and malignant tumours.

A Jacobs.   

Abstract

Increased concentrations of serum ferritin are common in patients with malignant disease and appear to be a non-specific response. The present evidence does not suggest that serum ferritin assay is useful either for specific diagnosis or monitoring of malignant disease. A special role for acidic isoferritins in malignancy remains to be substantiated.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6085815     DOI： 10.1007/bf02934136

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN： 0736-0118


  58 in total

1.  Increased ferritin synthesis and release by Hodgkin's disease peripheral blood lymphocytes.

Authors:  E J Sarcione; J R Smalley; M J Lema; L Stutzman
Journal:  Int J Cancer       Date:  1977-09-15       Impact factor: 7.396

2.  Ferritin in body fluids.

Authors:  C W Aungst
Journal:  J Lab Clin Med       Date:  1968-03

3.  Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release.

Authors:  A M Konijn; C Hershko
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

4.  Serum ferritin during unmaintained remission in acute lymphoblastic leukaemia.

Authors:  D H Parry; C Ricketts; A Jacobs
Journal:  Br Med J       Date:  1978-11-11

5.  Detection and isolation of a hepatic membrane receptor for ferritin.

Authors:  U Mack; L W Powell; J W Halliday
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

6.  Isoferritin composition of tissues and serum in human cancers.

Authors:  J W Halliday; L V McKeering; L W Powell
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

7.  An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.

Authors:  G M Addison; M R Beamish; C N Hales; M Hodgkins; A Jacobs; P Llewellin
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

8.  Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer.

Authors:  D M Marcus; N Zinberg
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

9.  Biochemical markers in human breast cancer.

Authors:  R C Coombes; T J Powles; J C Gazet; H T Ford; J P Sloane; D J Laurence; A M Neville
Journal:  Lancet       Date:  1977-01-15       Impact factor: 79.321

10.  Alteration in tryptic peptide patterns of ferritins purified from human colon carcinoma.

Authors:  E Alpert; A Quaroni; D M Goldenberg
Journal:  Biochim Biophys Acta       Date:  1979-11-23
View more
  7 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

Review 2.  A possible role for secreted ferritin in tissue iron distribution.

Authors:  Esther G Meyron-Holtz; Shirly Moshe-Belizowski; Lyora A Cohen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-06       Impact factor: 3.575

3.  Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study.

Authors:  Ronald T Acton; J Clayborn Barton; James C Barton
Journal:  Metab Syndr Relat Disord       Date:  2014-11-25       Impact factor: 1.894

Review 4.  Treatment of Pancreatic Cancer with Pharmacological Ascorbate.

Authors:  John A Cieslak; Joseph J Cullen
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

5.  Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study.

Authors:  James C Barton; J Clayborn Barton; Paul C Adams; Ronald T Acton
Journal:  Metab Syndr Relat Disord       Date:  2016-01-15       Impact factor: 1.894

6.  Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.

Authors:  K Pattanapanyasat; T G Hoy; A Jacobs; S Courtney; D J Webster
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

Review 7.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.